Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes

scientific article published on March 1984

Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4269/AJTMH.1984.33.197
P698PubMed publication ID6370001

P2093author name stringWilliams JL
Haynes JD
J. D. Haynes
Diggs CL
Vernes A
J. L. Williams
A. Vernes
Dutoit E
Tapchaisri P
C. L. Diggs
P. Tapchaisri
E. Dutoit
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmerozoiteQ2296434
Plasmodium falciparumQ311383
erythrocyte invasionQ122665572
merozoite invasionQ123944667
P1104number of pages7
P304page(s)197-203
P577publication date1984-03-01
P1433published inAmerican Journal of Tropical Medicine and HygieneQ15766943
P1476titlePlasmodium Falciparum Strain-Specific Human Antibody Inhibits Merozoite Invasion of Erythrocytes *
Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes
P478volume33

Reverse relations

cites work (P2860)
Q24643787A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A
Q39516438A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein.
Q37223728Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum
Q39515040Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids
Q43690388Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form
Q59138081Characterization of a Protein Phosphatase Type-1 and a Kinase Anchoring Protein in
Q33755404Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues.
Q28741027Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies
Q37235685Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood
Q35042128Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene
Q38314731Evidence for two-stage binding by the 175-kD erythrocyte binding antigen of Plasmodium falciparum
Q72314521H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen
Q27973366Identification of Plasmodium falciparum Translation Initiation eIF2β Subunit: Direct Interaction with Protein Phosphatase Type 1
Q33608668Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.
Q37141041Immunological characteristics of malaria antibodies in two regions of Madagascar
Q41914622In vitro growth and chloroquine sensitivity of Plasmodium falciparum (FCR-3 strain) in red blood cells containing HbC.
Q44409588Influence of medium osmolality on the in vitro growth of Plasmodium falciparum: a morphologic and radioisotopic study
Q36352701Invasion of mouse erythrocytes by the human malaria parasite, Plasmodium falciparum
Q35042373Microscopic and flow cytophotometric analysis of parasitemia in cultures of Plasmodium falciparum vitally stained with Hoechst 33342--application to studies of antimalarial agents
Q27974345PhosphoTyrosyl phosphatase activator of Plasmodium falciparum: identification of its residues involved in binding to and activation of PP2A
Q27972565Plasmodium falciparum dynein light chain 1 interacts with actin/myosin during blood stage development
Q30038953Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy
Q27973484Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival
Q92664225Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort
Q36349756Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum
Q42129581Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion
Q36943106Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum
Q36875983Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth
Q33512926The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria

Search more.